BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35189334)

  • 1. Leveraging electronic health record data for clinical trial planning by assessing eligibility criteria's impact on patient count and safety.
    Rogers JR; Pavisic J; Ta CN; Liu C; Soroush A; Kuen Cheung Y; Hripcsak G; Weng C
    J Biomed Inform; 2022 Mar; 127():104032. PubMed ID: 35189334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical comparison between trial participants and potentially eligible patients using electronic health record data: A generalizability assessment method.
    Rogers JR; Hripcsak G; Cheung YK; Weng C
    J Biomed Inform; 2021 Jul; 119():103822. PubMed ID: 34044156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards clinical data-driven eligibility criteria optimization for interventional COVID-19 clinical trials.
    Kim JH; Ta CN; Liu C; Sung C; Butler AM; Stewart LA; Ena L; Rogers JR; Lee J; Ostropolets A; Ryan PB; Liu H; Lee SM; Elkind MSV; Weng C
    J Am Med Inform Assoc; 2021 Jan; 28(1):14-22. PubMed ID: 33260201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of data completeness in the electronic health record for the purpose of patient recruitment into clinical trials: a retrospective analysis of element presence.
    Köpcke F; Trinczek B; Majeed RW; Schreiweis B; Wenk J; Leusch T; Ganslandt T; Ohmann C; Bergh B; Röhrig R; Dugas M; Prokosch HU
    BMC Med Inform Decis Mak; 2013 Mar; 13():37. PubMed ID: 23514203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of structured data elements from electronic health records for identifying subjects for primary care clinical trials.
    Ateya MB; Delaney BC; Speedie SM
    BMC Med Inform Decis Mak; 2016 Jan; 16():1. PubMed ID: 26754574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult patient access to electronic health records.
    Ammenwerth E; Neyer S; Hörbst A; Mueller G; Siebert U; Schnell-Inderst P
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD012707. PubMed ID: 33634854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leveraging Real-World Data for the Selection of Relevant Eligibility Criteria for the Implementation of Electronic Recruitment Support in Clinical Trials.
    Melzer G; Maiwald T; Prokosch HU; Ganslandt T
    Appl Clin Inform; 2021 Jan; 12(1):17-26. PubMed ID: 33440429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case-based reasoning using electronic health records efficiently identifies eligible patients for clinical trials.
    Miotto R; Weng C
    J Am Med Inform Assoc; 2015 Apr; 22(e1):e141-50. PubMed ID: 25769682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extraction and Prevalence of Structured Data Elements in Free-Text Clinical Trial Eligibility Criteria.
    Gulden C; Landerer I; Nassirian A; Altun FB; Andrae J
    Stud Health Technol Inform; 2019; 258():226-230. PubMed ID: 30942751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating predictive modeling algorithms to assess patient eligibility for clinical trials from routine data.
    Köpcke F; Lubgan D; Fietkau R; Scholler A; Nau C; Stürzl M; Croner R; Prokosch HU; Toddenroth D
    BMC Med Inform Decis Mak; 2013 Dec; 13():134. PubMed ID: 24321610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated safety event monitoring using electronic medical records in a clinical trial setting: Validation study using the VA NEPHRON-D trial.
    Huang Y; Fried LF; Kyriakides TC; Johnson GR; Chiu S; Mcdonald L; Zhang JH
    Clin Trials; 2019 Feb; 16(1):81-89. PubMed ID: 30445841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation.
    Hartwell D; Jones J; Baxter L; Shepherd J
    Health Technol Assess; 2011 Apr; 15(17):i-xii, 1-210. PubMed ID: 21473834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broadening Eligibility Criteria and Diversity among Patients for Cancer Clinical Trials.
    Kaur M; Frahm F; Lu Y; Ascha MS; Guadamuz JS; Dotan E; Gottesman AS; Leybovich BC; Sondhi A; Zhao Y; Meropol NJ; Royce TJ
    NEJM Evid; 2024 Apr; 3(4):EVIDoa2300236. PubMed ID: 38771994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eligibility and safety of the first interferon-free therapy against hepatitis C in a real-world setting.
    Höner Zu Siederdissen C; Maasoumy B; Deterding K; Port K; Sollik L; Mix C; Kirschner J; Cornberg J; Manns MP; Wedemeyer H; Cornberg M
    Liver Int; 2015 Jul; 35(7):1845-52. PubMed ID: 25556625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological interventions for acute hepatitis C infection.
    Kalafateli M; Buzzetti E; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011644. PubMed ID: 30521693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The opportunities and challenges of pragmatic point-of-care randomised trials using routinely collected electronic records: evaluations of two exemplar trials.
    van Staa TP; Dyson L; McCann G; Padmanabhan S; Belatri R; Goldacre B; Cassell J; Pirmohamed M; Torgerson D; Ronaldson S; Adamson J; Taweel A; Delaney B; Mahmood S; Baracaia S; Round T; Fox R; Hunter T; Gulliford M; Smeeth L
    Health Technol Assess; 2014 Jul; 18(43):1-146. PubMed ID: 25011568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine learning enabled subgroup analysis with real-world data to inform clinical trial eligibility criteria design.
    Xu J; Zhang H; Zhang H; Bian J; Wang F
    Sci Rep; 2023 Jan; 13(1):613. PubMed ID: 36635438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformity between protocol eligibility criteria for electronic patient identification: a comparison of clinical trials.
    Kamauu A; Agbor S; Kamauu A
    Stud Health Technol Inform; 2013; 192():1167. PubMed ID: 23920941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.